Replies to post #5928 on Vaxart Inc (VXRT)

[YJ4LIFE]

Many have suspected that they will report antibodies with a higher dose and its efficacy towards the variants in addition to even higher T-cell response. They may report on a possibility of getting more funds or partners. The oral vaccine as stated many times by experts, is one its kind and can be made easily available to large amount of pills and easily export out of the country and we already have several contracts signed with Malaysia and Africa if memory serves. Let’s wait and see what CEO has on the table on Tuesday. I don’t think they are going to waste time and money to do a CC just to go over the Q.

[YJ4LIFE]

Here is a copy and paste from Stocktwits. Interesting thoughts!

“Tuesday Vaxart will provide a Business "OUTLOOK" meaning what to look forward to.... this past Thursday they provided a Business "UPDATE" meaning what has come through fruition up to date...

Im guessing they will mention certain things on Tuesday such as:

-"Expected" non-dilutive funding
-plans for their Covid vaccine in children and for the South African variant.
-Plans for their current covid vaccine moving into P2 and possible P3 plans
-Plans to move forward in their Norovirus vaccine
-Possible plans to partner with other countries and big Pharma companies..
-Plans with their Flu vaccines in the future

they will also mention certain things such as their money on hand. Maybe an update on P1 IGg growth.

These are all great things! if the world is a normal place, we can expect this to increase the share price... We will need more publicity though, since it is after hours... alot of manipulators can fluctuate the price and confuse simple minded traders into thinking good news is bad news... so if the news gets publicized well then we should be fine..”

[Obtuse Eye]

As long as we continue to see variants to this, then there is still massive opportunity.

Also, as has been the major appeal in Vaxart’s corner is that they are still the only pill in the making from the vaccine realm. This may not have the opportunity to get to the levels where Moderna and the others who were fast-tracked through the system. But I think it can still make a healthy splash. If they can smoke Phase II and get up into phase 3 before Summer they may still get pushed through for an early 2022 rollout.